Business Description
Prostatype Genomics AB
ISIN : SE0014684569
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.56 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.84 | |||||
Beneish M-Score | 1.79 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.5 | |||||
3-Year EBITDA Growth Rate | -6.6 | |||||
3-Year EPS without NRI Growth Rate | -8.3 | |||||
3-Year FCF Growth Rate | -2.8 | |||||
3-Year Book Growth Rate | 19.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.77 | |||||
9-Day RSI | 34.12 | |||||
14-Day RSI | 37.53 | |||||
6-1 Month Momentum % | -49.46 | |||||
12-1 Month Momentum % | -79.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.72 | |||||
Quick Ratio | 2.69 | |||||
Cash Ratio | 2.1 | |||||
Days Sales Outstanding | 246.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.9 | |||||
Shareholder Yield % | -47.82 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -3901.51 | |||||
Net Margin % | -3948.72 | |||||
FCF Margin % | -4194.87 | |||||
ROE % | -130.22 | |||||
ROA % | -108.16 | |||||
ROIC % | -170.63 | |||||
ROC (Joel Greenblatt) % | -106427.22 | |||||
ROCE % | -126.21 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.35 | |||||
PB Ratio | 0.27 | |||||
Price-to-Tangible-Book | 0.32 | |||||
EV-to-EBIT | -0.88 | |||||
EV-to-EBITDA | -0.93 | |||||
EV-to-Revenue | 34.25 | |||||
EV-to-FCF | -0.86 | |||||
Earnings Yield (Greenblatt) % | -114.28 | |||||
FCF Yield % | -90.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Prostatype Genomics AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.078 | ||
EPS (TTM) (€) | -0.025 | ||
Beta | 2.21 | ||
Volatility % | 240.94 | ||
14-Day RSI | 37.53 | ||
14-Day ATR (€) | 0.000958 | ||
20-Day SMA (€) | 0.00422 | ||
12-1 Month Momentum % | -79.96 | ||
52-Week Range (€) | 0.0026 - 0.095371 | ||
Shares Outstanding (Mil) | 990.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Prostatype Genomics AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Prostatype Genomics AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Prostatype Genomics AB Frequently Asked Questions
What is Prostatype Genomics AB(FRA:PGO)'s stock price today?
When is next earnings date of Prostatype Genomics AB(FRA:PGO)?
Does Prostatype Genomics AB(FRA:PGO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |